Cargando…
CY-fTBI与BMM预处理方案行异基因造血干细胞移植治疗Ⅲ、Ⅳ期非霍奇金淋巴瘤:15年单中心疗效分析
OBJECTIVE: To investigate the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of patients with Ⅲ,Ⅳ non-Hodgkin lymphoma (NHL), and compared the efficacy between Cy-fractionated to talbody irradiation (fTBI) based conditioning regimen and Maryland, horse fl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364953/ https://www.ncbi.nlm.nih.gov/pubmed/26477760 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.10.005 |
Ejemplares similares
-
霍奇金淋巴瘤治疗进展
Publicado: (2019) -
IGEV方案治疗复发难治性霍奇金淋巴瘤的临床研究
Publicado: (2018) -
苯达莫司汀单药治疗复发/难治B细胞非霍奇金淋巴瘤:一项前瞻、多中心、单臂、Ⅱ期临床研究
Publicado: (2022) -
CBV、BEAM和BEAC预处理方案用于霍奇金淋巴瘤自体造血干细胞移植的疗效与安全性比较
Publicado: (2017) -
卡瑞利珠单抗联合AVD方案一线治疗经典型霍奇金淋巴瘤的有效性和安全性
Publicado: (2022)